Samantha C. Fisch

发表

Accelerated subcutaneous abdominal stem cell adipogenesis predicts insulin sensitivity in normal-weight women with polycystic ovary syndrome.

D. Abbott, T. Grogan, D. Dumesic, 2020, Fertility and sterility.

Precocious Subcutaneous Abdominal Stem Cell Development to Adipocytes in Normal-Weight Polycystic Ovary Syndrome Women

T. Grogan, D. Dumesic, Karen L. Leung, 2018 .

Phase I trial of the combination of ibrutinib and lenalidomide of the treatment of patients with MDS who have failed standard therapy or who are unfit for or refuse standard therapy.

J. Tuscano, B. Jonas, L. Qi, 2022, Leukemia research.

Phase I study of escalating doses of carfilzomib with HyperCVAD in patients with newly diagnosed acute lymphoblastic leukemia

J. Tuscano, M. Abedi, B. Jonas, 2021, American journal of hematology.

Pluripotent nontumorigenic multilineage differentiating stress enduring cells (Muse cells): a seven-year retrospective

D. Dumesic, G. Chazenbalk, M. Perone, 2017, Stem Cell Research & Therapy.

Pregnancy outcomes in women with sickle cell disease in California

T. Keegan, A. Mahajan, A. Brunson, 2023, American journal of hematology.

Precocious subcutaneous abdominal stem cell development to adipocytes in normal-weight women with polycystic ovary syndrome.

D. Abbott, T. Grogan, D. Dumesic, 2018, Fertility and sterility.

Pluripotent nontumorigenic multilineage differentiating stress enduring cells (Muse cells): a seven-year retrospective

D. Dumesic, G. Chazenbalk, M. Perone, 2017, Stem Cell Research & Therapy.

Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center.

P. Kaesberg, J. Tuscano, J. Welborn, 2022, Leukemia research.